120 related articles for article (PubMed ID: 4010780)
1. Osmotic stress mimics effects of vasopressin on learned behaviour.
Koob GF; Dantzer R; Rodriguez F; Bloom FE; Le Moal M
Nature; 1985 Jun 27-Jul 3; 315(6022):750-2. PubMed ID: 4010780
[TBL] [Abstract][Full Text] [Related]
2. Vasopressin pressor antagonist injected centrally reverses behavioral effects of peripheral injection of vasopressin, but only at doses that reverse increase in blood pressure.
Lebrun C; Le Moal M; Koob GF; Bloom FE
Regul Pept; 1985 Jun; 11(2):173-81. PubMed ID: 4035008
[TBL] [Abstract][Full Text] [Related]
3. Arginine vasopressin, stress, and memory.
Koob GF; Lebrun C; Martinez JL; Dantzer R; Le Moal M; Bloom FE
Ann N Y Acad Sci; 1985; 444():194-202. PubMed ID: 3860087
[TBL] [Abstract][Full Text] [Related]
4. Arginine vasopressin and a vasopressin antagonist peptide: opposite effects on extinction of active avoidance in rats.
Koob GF; Le Moal M; Gaffori O; Manning M; Sawyer WH; Rivier J; Bloom FE
Regul Pept; 1981 Jun; 2(3):153-63. PubMed ID: 7255768
[TBL] [Abstract][Full Text] [Related]
5. Hypertonic saline mimics the effects of vasopressin on inhibitory avoidance in the rat.
Lebrun C; Le Moal M; Dantzer R; Bloom FE; Koob GF
Behav Neural Biol; 1987 Mar; 47(2):130-7. PubMed ID: 3579833
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of effects of vasopressin (AVP) on inhibitory avoidance by a vasopressin antagonist peptide [dPtyr(Me)AVP].
LeBrun CJ; Rigter H; Martinez JL; Koob GF; Le Moal M; Bloom FE
Life Sci; 1984 Oct; 35(14):1505-12. PubMed ID: 6482669
[TBL] [Abstract][Full Text] [Related]
7. Vascular effects of arginine vasopressin during fluid deprivation in the rat.
Aisenbrey GA; Handelman WA; Arnold P; Manning M; Schrier RW
J Clin Invest; 1981 Apr; 67(4):961-8. PubMed ID: 7204578
[TBL] [Abstract][Full Text] [Related]
8. Role of neuropeptides in learning versus performance: focus on vasopressin.
Koob GF; Lebrun C; Bluthé RM; Dantzer R; Le Moal M
Brain Res Bull; 1989; 23(4-5):359-64. PubMed ID: 2686806
[TBL] [Abstract][Full Text] [Related]
9. Central target for the behavioural effects of vasopressin neuropeptides.
de Wied D; Gaffori O; van Ree JM; de Jong W
Nature; 1984 Mar 15-21; 308(5956):276-8. PubMed ID: 6322010
[TBL] [Abstract][Full Text] [Related]
10. Central injections of arginine vasopressin prolong extinction of active avoidance.
Koob GF; Dantzer R; Bluthé RM; Lebrun C; Bloom FE; Le Moal M
Peptides; 1986; 7(2):213-8. PubMed ID: 3737445
[TBL] [Abstract][Full Text] [Related]
11. The vasopressin receptor antagonist dPTyr (Me) AVP does not prevent stress-induced ACTH and corticosterone release.
Mormède P
Nature; 1983 Mar 24-30; 302(5906):345-6. PubMed ID: 6300679
[TBL] [Abstract][Full Text] [Related]
12. Can vasopressin alone act as an unconditioned stimulus to produce passive avoidance behaviour in rats in a typical memory experiment?
Ebenezer IS
Neuropharmacology; 1988 Sep; 27(9):903-7. PubMed ID: 3185866
[TBL] [Abstract][Full Text] [Related]
13. Time-related memory effects of vasopressin analogues in rats.
Gaffori OJ; De Wied D
Pharmacol Biochem Behav; 1986 Dec; 25(6):1125-9. PubMed ID: 3809214
[TBL] [Abstract][Full Text] [Related]
14. Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat.
Rivier C; Rivier J; Mormede P; Vale W
Endocrinology; 1984 Sep; 115(3):882-6. PubMed ID: 6086290
[TBL] [Abstract][Full Text] [Related]
15. Increased motor disturbances in response to arginine vasopressin following hemorrhage or hypertonic saline: evidence for central AVP release in rats.
Burnard DM; Pittman QJ; Veale WL
Brain Res; 1983 Aug; 273(1):59-65. PubMed ID: 6616233
[TBL] [Abstract][Full Text] [Related]
16. Pulsatile arginine vasopressin release from the rat hypothalamo neurohypophyseal system during osmotic stimulation.
Ohno N
Acta Med Okayama; 1981 Jun; 35(3):205-13. PubMed ID: 6457510
[TBL] [Abstract][Full Text] [Related]
17. Can aversive properties of (peripherally-injected) vasopressin account for its putative role in memory?
Ettenberg A; van der Kooy D; Le Moal M; Koob GF; Bloom FE
Behav Brain Res; 1983 Mar; 7(3):331-50. PubMed ID: 6838716
[TBL] [Abstract][Full Text] [Related]
18. Neonatal administration of vasopressin antiserum induces long-term deficits on active and passive avoidance behaviour in rats.
Moratalla R; Borrell J; Sanchez-Franco F; Del Rio J
Behav Brain Res; 1987 Mar; 23(3):231-7. PubMed ID: 3580108
[TBL] [Abstract][Full Text] [Related]
19. Vasopressin and oxytocin. Their presence in the central nervous system and their functional significance in brain processes related to behaviour and memory.
van Wimersma Greidanus TB; Burbach JP; Veldhuis HD
Acta Endocrinol Suppl (Copenh); 1986; 276():85-94. PubMed ID: 3463110
[TBL] [Abstract][Full Text] [Related]
20. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
Endocrinology; 1986 Jul; 119(1):1-11. PubMed ID: 3720659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
